Related Experiment Video
Updated: Jul 23, 2025

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
15.8K
Advancing Cancer Research: Current Knowledge on Cutaneous Neoplasia
Laura Stătescu1, Laura Mihaela Trandafir2, Elena Țarcă3
1Medical III Department, Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.
International Journal of Molecular Sciences
|July 14, 2023
Summary
Updated guidelines offer new insights for managing skin cancers, including melanoma, basal cell carcinoma, squamous cell carcinoma, sebaceous carcinoma, and primary cutaneous lymphomas. A multidisciplinary approach is crucial for optimal patient outcomes in skin cancer treatment.
Area of Science:
- Dermatology
- Oncology
- Pathology
Background:
- Skin cancers, including melanoma (MM), basal cell carcinoma (BCC), and squamous cell carcinoma (cSCC), are increasingly prevalent and require effective management strategies.
- Melanoma, a potentially lethal skin cancer, shows higher mortality-incidence ratios in Eastern Europe, highlighting the need for improved prevention and early detection.
- Sebaceous carcinoma (SeC) and primary cutaneous lymphomas (PCLs) are less common but aggressive malignancies requiring specialized treatment approaches.
Purpose of the Study:
- To summarize recent advancements and guideline updates in the multidisciplinary management of various skin cancers.
- To highlight the importance of early detection and tailored treatment for different skin cancer types, including melanoma, non-melanoma skin cancers, and cutaneous lymphomas.
- To emphasize the necessity of a collaborative, multidisciplinary approach involving dermatology, medical oncology, and radiation oncology for optimal patient care.
Main Methods:
- Review of updated clinical guidelines and recent literature on skin cancer management.
- Synthesis of information on diagnosis, histopathological classification, and treatment modalities for melanoma, BCC, cSCC, SeC, and PCLs.
- Analysis of epidemiological data, such as mortality-incidence ratios, to identify regional disparities in skin cancer outcomes.
Main Results:
- Updated guidelines provide new insights into managing melanoma, BCC, cSCC, SeC, and PCLs.
- Skin biopsy remains the gold standard for diagnosing BCC and cSCC, while Mohs micrographic surgery is advantageous for SeC due to low recurrence rates.
- Melanoma management requires attention to histological subtypes and regional differences in outcomes, with higher mortality in Eastern Europe.
Conclusions:
- Optimal management of all skin cancers necessitates a multidisciplinary approach integrating dermatology, medical oncology, and radiation oncology.
- Early detection and tailored treatment strategies are critical for improving outcomes, particularly for aggressive skin cancers like melanoma and sebaceous carcinoma.
- Addressing regional disparities in prevention and early detection is essential for reducing skin cancer mortality globally.
Related Concept Videos
Skin Cancer
4.2K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Vaccines
419
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
419
Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
Cancer Survival Analysis
394
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
394

